Philip Morris (PM) Stock Forecast & Price Target

Philip Morris Intl is a strong investment opportunity, with a Buy rating and raised target price, as they expand their product offerings in both US and international markets. Their focus on reducing debt, increasing dividends, and achieving growth targets through strong cash flow also shows a promising financial outlook. Launching a new nicotine pouch and expanding their non-tobacco portfolio further diversifies their revenue streams and has the potential to capture a significant market share within 5 years. While challenges in Japan and Poland may pose a risk to their dominant product, IQOS, the company's commitment to transitioning to a smoke-free business and obtaining FDA authorization for their products showcases their long-term strategic planning. Overall, Philip Morris Intl is a favorable investment opportunity with a strong potential for growth.

Philip Morris Intl is facing challenges in its US business with the delayed authorization of IQOS ILUMA launch by the FDA, even as the ZYN portfolio continues to expand. The company's exposure to traditional combustible products and the challenges of the US tobacco market may hinder its growth potential. Furthermore, the contribution of the ZYN brand to the company's overall sales and operating profit is relatively modest, and uncertainties around the rollout of ZYN Ultra may impact its financial performance. Overall, the company may struggle to achieve significant growth and market share gains in the coming years, making it a risky investment for the long term.